Medical knowledge · Legal judgment · Human agency

Litigation Tracker

Active Lawsuits & Litigation Tracker

Track major ongoing pharmaceutical, medical device, and healthcare litigation. Browse by case type, litigation status, plaintiff count, and defendant. Find out if you may qualify for a claim and get connected with experienced legal counsel.

What You'll Find Here

This page is designed as a front door into the MD Law litigation-tracking system.

Users come here for different reasons. Some already suspect a specific product harmed them. Others only know that something went wrong and want to see whether a known lawsuit matches their experience. Some are comparing firms. Some are trying to understand whether a recall, an MDL, or a mass tort affects them.

This hub is built to make that process clearer.

Here you can explore:

  • •Active dangerous drug lawsuits
  • •Active medical device lawsuits
  • •Product recalls and related claims
  • •Litigation and investigation pages
  • •Qualification guidance
  • •Broader educational resources on how these claims work

This is not a list of every lawsuit in America. It is a structured starting point for the major categories most relevant to serious medical-product injury litigation.

Featured Active Lawsuits

Ozempic Lawsuit

Current litigation includes allegations involving severe gastrointestinal injury and related complications associated with Ozempic and similar medications in some users.

Wegovy Lawsuit

Lawsuit activity involving Wegovy has drawn attention to similar alleged gastrointestinal injuries and product-risk questions.

Mounjaro Lawsuit

Claims involving Mounjaro and related GLP-1 medications continue to raise product-liability and causation questions in active litigation.

Tepezza Hearing Loss Lawsuit

Current claims involve allegations of serious or permanent hearing-related injury associated with Tepezza treatment.

Elmiron Eye Injury Lawsuit

Litigation involving Elmiron has focused on allegations of vision-related injury associated with long-term use in certain patients.

View All Dangerous Drug Lawsuits

How to Use This Resource

Not everyone arrives with the same level of information. The best starting point depends on what you already know.

If you know the product name

Start with the specific lawsuit page for that drug or device.

If you know the injury but not the legal category

Browse the dangerous drug or medical device sections, then use related pages to narrow the issue.

If the product was recalled or investigated

Review both the recall-related page and the underlying lawsuit page. A recall and a viable legal claim are related, but they are not identical.

If you are not sure whether you qualify

Use the qualification-oriented pages and then move to a case review if the timeline, injury, and product seem to match.

The goal is not to rush you into a conclusion. It is to help you identify the right path with less confusion.

How Active Lawsuits Usually Work

Lawsuits involving drugs and devices can take different forms. Some are filed individually. Some are coordinated in large groups. Some become multidistrict litigation. Some involve bellwether trials, settlement programs, or evolving qualification standards.

What matters for most users at the start is simpler:

  • what product was involved
  • what injury is alleged
  • whether the claim is currently active
  • whether the person's records and timeline fit the pattern being litigated
  • whether the case appears strong enough to justify further review

That is why the existence of a lawsuit is not the end of the analysis. It is usually the beginning.

Active Lawsuits by Category

Dangerous Drugs

Explore litigation involving prescription medications, alleged failure-to-warn issues, severe adverse events, and evolving pharmaceutical claims.

Defective Medical Devices

Explore litigation involving recalled or allegedly defective implants, devices, surgical products, and medical hardware.

Qualification and Process

Explore pages that explain how these claims are evaluated and what may matter most in determining whether a case is viable.

State and Legal Context

Explore state-specific pages and legal-process resources that may matter once a claim appears viable.

What May Affect Whether You Qualify

Stronger Basis for Review

A person may have a stronger basis for further review when several of the following are present:

  • Documented exposure to the product
  • A serious, medically recognized injury
  • A reasonable timeline connecting product use and harm
  • Records showing diagnosis, treatment, and resulting damages
  • A product already associated with active litigation or serious investigation
  • A viable legal theory supported by the broader litigation pattern

Potentially Weaker Claim

A person may have a weaker claim when:

  • The injury is vague
  • Minimally documented
  • Weakly connected to the product
  • Overshadowed by stronger alternative causes

This is one reason serious case evaluation matters. The legal system tends to care less about whether something feels unfair than whether it can be shown carefully and convincingly.

Why MD Law Tracks Active Lawsuits

The Standard Approach

Many legal websites treat lawsuit pages as glorified bait. They throw around product names, hint at catastrophe, and hope the form fills itself out.

Our Approach

MD Law is built differently.

The purpose of this resource is to create structure around evolving litigation so users can understand:

  • •what the product is
  • •what injuries are being alleged
  • •whether the litigation is active
  • •what evidence may matter
  • •how the claim type generally works
  • •what next step makes sense

The aim is clarity first, conversion second. Ironically, that is usually what converts better anyway.

Frequently Asked Questions

Find the Right Litigation Path

If you believe a drug or medical device may have caused serious harm, start by identifying the right lawsuit category, understanding the injury pattern, and preserving the records that matter.

Structured. Current-minded. Built for serious claims.